Description
Composition Midostaurin Soft Gelatin 25mg
Substitutes Rydapt
Shipping class Room Temperature
Medicine Overview of Midostar 25mg 28 Capsules
Uses of Midostar 25mg 28 Capsules
Midostar contains Midostaurin, a multi-targeted kinase inhibitor. It is used in combination with chemotherapy for the treatment of newly diagnosed FLT3 mutation-positive acute myeloid leukemia (AML). It is also indicated for aggressive systemic mastocytosis (ASM), systemic mastocytosis with associated hematological neoplasm (SM-AHN), and mast cell leukemia (MCL).
Midostar 25mg 28 Capsules side effects
Common
Nausea, Vomiting, Diarrhea, Febrile neutropenia, Headache, Fatigue, Stomatitis, Upper respiratory tract infection, Hyperglycemia, Epistaxis, Musculoskeletal pain
How to use Midostar 25mg 28 Capsules
Take Midostar exactly as prescribed by your doctor. The capsules should be taken orally with food at approximately the same time each day. Swallow the capsules whole and do not crush, chew, or open them. Dosage depends on the condition being treated and concurrent chemotherapy regimen.
How Midostar 25mg 28 Capsules works
Midostar works by inhibiting multiple protein kinases including FLT3 and KIT kinases. By blocking these abnormal signaling pathways, Midostaurin helps slow down the growth and proliferation of cancer cells and mast cells.
In Depth Information on Midostar 25mg 28 Capsules
Expert advice for Midostar 25mg 28 Capsules
- Regular blood count monitoring is required during treatment due to the risk of neutropenia and anemia.
- Patients should be monitored for pulmonary symptoms such as cough or shortness of breath because interstitial lung disease and pneumonitis may occur.
- Electrocardiogram (ECG) and electrolyte monitoring are recommended as Midostaurin may prolong the QT interval.
- Avoid strong CYP3A4 inhibitors and inducers as they may alter Midostaurin blood concentrations.
- Use effective contraception during treatment and for at least 4 months after the last dose.
Midostar 25mg 28 Capsules related warnings
Special precautions for Midostar 25mg 28 Capsules
Alcohol
Interaction with alcohol is not well established. Patients should consult their doctor before consuming alcohol during therapy.
Pregnancy
unsafe
Midostar may cause fetal harm when administered during pregnancy. Use effective contraception and avoid use during pregnancy unless clearly necessary.
Lactation
unsafe
Breastfeeding is not recommended during treatment and for at least 4 months after the final dose.
Driving
caution
Midostar may cause dizziness or fatigue in some patients. Use caution while driving or operating machinery.
Kidney
caution
Use with caution in patients with severe renal impairment. Clinical monitoring is recommended.
Liver
caution
Monitor liver function tests regularly during treatment. Dose adjustment or discontinuation may be necessary in severe hepatic impairment.
What if you miss a dose of Midostar 25mg 28 Capsules?
If a dose is missed, take the next scheduled dose at the regular time. Do not take an extra dose to make up for the missed dose.
